NGL Fine-Chem Limited

BSE:524774 Rapport sur les actions

Capitalisation boursière : ₹12.4b

NGL Fine-Chem Bilan de santé

Santé financière contrôle des critères 6/6

NGL Fine-Chem has a total shareholder equity of ₹2.6B and total debt of ₹340.0M, which brings its debt-to-equity ratio to 12.9%. Its total assets and total liabilities are ₹3.6B and ₹929.0M respectively. NGL Fine-Chem's EBIT is ₹409.7M making its interest coverage ratio 86.1. It has cash and short-term investments of ₹553.1M.

Informations clés

12.9%

Ratio d'endettement

₹340.04m

Dette

Ratio de couverture des intérêts86.1x
Argent liquide₹553.14m
Fonds propres₹2.63b
Total du passif₹929.04m
Total des actifs₹3.56b

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

Analyse de la situation financière

Passif à court terme: 524774's short term assets (₹2.1B) exceed its short term liabilities (₹865.9M).

Passif à long terme: 524774's short term assets (₹2.1B) exceed its long term liabilities (₹63.2M).


Historique et analyse du ratio d'endettement

Niveau d'endettement: 524774 has more cash than its total debt.

Réduire la dette: 524774's debt to equity ratio has reduced from 29.5% to 12.9% over the past 5 years.

Couverture de la dette: 524774's debt is well covered by operating cash flow (60.2%).

Couverture des intérêts: 524774's interest payments on its debt are well covered by EBIT (86.1x coverage).


Bilan


Découvrir des entreprises saines